We are pleased to announce that the 6th pilot rapid assessment of WP5 JA2 Strand B on “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke” is available.

This assessment examines the effectiveness and safety of mechanical thrombectomy in adults aged 18 years or older with acute ischaemic stroke in the anterior and/or posterior region. The analysis included CE-marked aspiration/suction devices, and stent and clot retrievers.

More than 15 million people worldwide suffer a stroke each year. In 2012, stroke was the third most common cause of death in developed countries and the most common cause in upper-middle-income countries.

Intravenous thrombolysis with tissue plasminogen activator (tPA) remains the standard medical treatment for acute stroke. This assessment evaluates mechanical thrombectomy administered as an adjunct to usual care, such as tPA alone.

Find the joint assessment here.